Nano-graphene promises more effective treatment for Hepatitis C
The researchers developed a method for delivering the DNAzyme into cells by preparing a complex of the enzyme and nano-sized graphene oxide. The nano-graphene prevents the DNAzyme from being degraded by other enzymes in the infected cells, allowing it to reach the target disease gene.
The team tagged the complex with a fluorescent dye and observed its activity in live liver cells. They found that the complex was able to enter the cells and indicate the presence of hepatitis C virus NS3 RNA in infected cells with a fluorescence signal. They also showed the complex could knock down NS3 gene expression, potentially inhibiting replication of the virus.
Most read news
Original publication
Organizations
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.